ProPhase Labs PRPH
OTC PRPH
$0.01 0.00 (-9.47%)
As of: Oct 23, 2026 · 11:54 AM EDT

ProPhase Labs (PRPH) Long-Term Investments (2025 - 2026)

Updated

ProPhase Labs (PRPH) recorded Long-Term Investments of $43.22 million in Q2 2026, down 0.1% from the prior quarter.

Analysis

ProPhase Labs (PRPH) Long-Term Investments (2025 - 2026) Analysis & Trends

At the end of FY2025, ProPhase Labs reported Long-Term Investments of $43.49 million.

  • Per Business Quant, the preceding three quarters came in at $43.27 million (Q1 2026), $43.49 million (Q4 2025) and $43.66 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn 3.86 Bn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn -
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn 266.00 Mn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn 1.22 Bn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn 69.00 Mn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn 297.00 Mn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn -
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn 1.56 Bn
10 ProPhase Labs 120,537.60 -425,462.40 226,000.00 43.22 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 43.22 Mn
Mar 31, 2026 43.27 Mn
Dec 31, 2025 43.49 Mn
Sep 30, 2025 43.66 Mn
API Access

ProPhase Labs Long-Term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-investments&ticker=PRPH&period=max&api_key=YOUR_API_KEY